Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-25 @ 2:20 AM
NCT ID:
NCT03853434
Eligibility Criteria:
Inclusion Criteria:
* Male, Female aged 18 years and 75 years
* prognosis \>6 months (Tokuhashi score ≤ 11)
* patients with lesions with moderate vascularization (grade 2)
* time between embolization and intervention \>/= 48-72 h
Exclusion Criteria:
* congenital and iatrogenic hemocoagulative disorders (PT INR\> 1.5, aPTT ratio\> 1.25 with documented coagulation factor deficiency, PLT \< 80,000 / microL or known coagulation pathologies);
* renal failure (creatinine ≥ 1.2);
* MDC iodized allergy;
* pregnancy / lactation;
* chronic ischemic heart disease;
* precluded arterial access by angiography;
* indication to emergency surgery;
* time between embolization and surgery\> 72 h;
* refusal by the patient.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03853434
Study Brief:
Protocol Section:
NCT03853434